How do you all feel about the GLP-1 market? It is projected to hit $100 billion by 2030 but personally I think Ozempic is about 10 years away from a sad commercial that says "did you take Ozempic between 2024 and 2026? You may be entitled to compensation."
The drug clearly works. We see the commercials every day and Charles Barkley has never been this skinny in his life. But the whole thing feels too good to be true.
I get that some people are using it as a tool while genuinely changing their habits. But let's be honest, a lot of people are taking the shot and continuing the exact lifestyle that got them larger than life.
Studies are even showing significant muscle loss in users and a large percentage of people gain the weight back shortly after stopping.
Meanwhile Novo Nordisk is already facing thousands of lawsuits over gastroparesis and other side effects and nobody knows the 20 year profile of a drug that has only been mainstream for five years.
NVO is down 70% from its all time high right now.
You buying the dip or steering clear?
How do you all feel about the GLP-1 market?
byu/Responsible-Jury2579 instocks
Posted by Responsible-Jury2579
4 Comments
Starting to get saturated quickly with different brands. Lot of money in easy weight loss but its getting spread out across many different brands.
Very happy, been owning LLY since $60/share
1. Ozempic has been around since 2017 for Type 2 Diabetes, so it has pretty solid evidence of minimal risks/side effects.
2. The economic costs of obesity are hundreds of billions annually. In just the US. It’s massively welfare improving for pretty much every government on this planet to subsidize the costs.
I mean, Tylenol is used by billions of people… but no one is rushing out to buy Kenvue (which is down 20% over the past 12 months).
Once medications become commodified, no one cares as profit margins get crushed. GLP1s are basically almost there.
For example, NVO’s profit margin is 33%. Kenvue’s is 9%.